Precision Microwave Energy, Redefining Treatment Boundaries
By integrating Traditional Chinese Medicine Meridian Theory with Western Microwave Physics, we have developed a systematic product that solves defects with clear causal logic. Thereby pioneering a novel medical system grounded in targeted microwave energy modulation.
Explore The Technology
Platform Overview
The Multi-Probe Microwave Therapy Instrument is presented as a research-stage equipment platform for non-invasive acupoint stimulation.
Its architecture combines guided controls, operator visibility, physical patient positioning support, and probe-based operation into a single equipment environment.
For the US market, the product should be understood as an investigational platform under FDA application and review rather than a cleared therapeutic device.
Core Components
Component 01
Integrated Control Board
The control interface manages device operation and supports protocol-based adjustment of applicator settings within the overall system environment.
Component 02
Display Monitor
The monitor provides visual guidance, including acupoint reference information, to support more consistent equipment positioning and workflow visibility.
Component 03
Treatment Bed
The height-adjustable treatment bed is designed to support operator access and patient positioning with an emphasis on comfort and stability.
Component 04
Probe Operation Console
The operator console is designed to help guide applicator placement and improve usability during platform setup and operation.
Design Principles
Non-Invasive
The platform is described around external stimulation concepts rather than penetrating instrumentation.
Precision-Guided
Visual guidance and component layout aim to support more structured operator workflow.
Operator-Friendly
The system design emphasizes usability, positioning clarity, and an integrated equipment experience.
Platform Overview
The LXH-WB105X Mobile Microwave Therapeutic Apparatus is presented as an advanced hardware platform engineered for clinical energy management and targeted physical stimulation.
Its architecture streamlines flexible clinical deployment, integrating specialized electromagnetic field delivery, localized power configurations, and a compact transport infrastructure into a single cohesive equipment environment.
For the US market, the product should be understood as an investigational platform under FDA application and review rather than a cleared therapeutic device.
System Components
The platform consists of three core structural modules designed to maximize clinical adaptability and operational precision:
Component 01
Desktop Module Base
Serves as the central command enclosure housing the core high-frequency microwave generators. It features a space-optimized footprint measuring exactly 365*289*287mm.
Component 02
Flexible Applicator System
Houses the targeted non-contact delivery probes, supporting a continuously adjustable microwave power range of 0 W to 60 W. It features an ultra-fine power tuning interface to scale energy safely based on specific localized clinical parameters.
Component 03
Compact Mobility Module
A high-density, robust cabinet enclosure weighing 22kg and equipped with heavy-duty casters. It enables effortless, stable physical transport between varied clinical spaces while acting as an electromagnetic shield for internal components.
Design Principles & Technical Specs
The engineering framework of the LXH-WB105X platform relies on three definitive baseline performance standards:
Principle 01
Stable Field Delivery
Engineered to output a highly stable continuous wave at a primary operating frequency of 2450 MHz, ensuring uniform and predictable physical stimulation.
Principle 02
Integrated Thermal Management
Utilizes a proprietary internal forced-air convection system that continuously cools the chassis, ensuring operational safety and hardware longevity during extended power delivery.
Principle 03
Operator-Friendly
The device is typically compact in size with an intuitive and straightforward workflow, allowing medical staff to operate it proficiently after brief training.
Regulatory and Commercial Status Disclosure
The statements presented on this website and the associated product have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
All technological principles, scientific research outcomes, and medical device products (including but not limited to Models LXH-WB101D and LXH-WB105X), as well as related therapeutic descriptions displayed on this website (specifically within the Technology and Product sections), are owned and exclusively controlled by our parent company, Henan Lixinghe Medical Technology Co., Ltd., located in China. The parent company retains all intellectual property rights and proprietary interests in these materials.
These technologies and products are being evaluated for regulatory compliance, clinical use, and U.S. market entry. The U.S. office and subsidiary, LiHe NeoSyn BioMeridian Technology Inc., do not engage in commercial sales, distribution, marketing, or clinical therapeutic services in the United States at this time.
All content on this website is for academic exchange, technical communication, and representing our parent company's background. Nothing here is an offer for sale or lease in the U.S. market.